Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute

Company continues to engage leading cancer treatment centers to investigate non-invasive methods of cancer mutation detection in order to advance patient care

Jun 16, 2014, 08:00 ET from Trovagene, Inc.

$countyNameToPathMap.put("sp